NASDAQ:MMSI 9 January 2026 - 11 January 2026

Merit Medical shares fell 7.3% to $86.38 Friday after the company reported preliminary Q4 revenue of $389 million to $395 million and announced a board leadership change. Founder Fred Lampropoulos resigned as chair, replaced by F. Ann Millner. Lampropoulos will serve as a consultant for $250,000 per month. Full 2025 results and 2026 guidance are due Feb. 24.

Merit Medical shares fell 8.1% to $85.66 Friday after the company posted preliminary Q4 revenue of $389 million–$395 million and named F. Ann Millner board chair, replacing founder Fred Lampropoulos. The stock touched $84.75. Full results and 2026 guidance are due Feb. 24. Lampropoulos will serve as a consultant through March.